<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/9C932CFE-AAE2-4A8F-A53F-1C7EAC961997"><gtr:id>9C932CFE-AAE2-4A8F-A53F-1C7EAC961997</gtr:id><gtr:name>Harvard University</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/C7FBE408-C743-4AAC-9BC6-65E14BC8D2FD"><gtr:id>C7FBE408-C743-4AAC-9BC6-65E14BC8D2FD</gtr:id><gtr:name>Karolinska Institute</gtr:name><gtr:address><gtr:line1>Administration</gtr:line1><gtr:line4>Stockholm</gtr:line4><gtr:postCode>SE-171 77</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Sweden</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/103D3F37-4066-444D-93DA-A10CF99F10F5"><gtr:id>103D3F37-4066-444D-93DA-A10CF99F10F5</gtr:id><gtr:name>Austrian Academy of Sciences</gtr:name><gtr:address><gtr:line1>Lazarettgasse 14</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:department>Sch of Biological Sciences</gtr:department><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9C932CFE-AAE2-4A8F-A53F-1C7EAC961997"><gtr:id>9C932CFE-AAE2-4A8F-A53F-1C7EAC961997</gtr:id><gtr:name>Harvard University</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C7FBE408-C743-4AAC-9BC6-65E14BC8D2FD"><gtr:id>C7FBE408-C743-4AAC-9BC6-65E14BC8D2FD</gtr:id><gtr:name>Karolinska Institute</gtr:name><gtr:address><gtr:line1>Administration</gtr:line1><gtr:line4>Stockholm</gtr:line4><gtr:postCode>SE-171 77</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Sweden</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/103D3F37-4066-444D-93DA-A10CF99F10F5"><gtr:id>103D3F37-4066-444D-93DA-A10CF99F10F5</gtr:id><gtr:name>Austrian Academy of Sciences</gtr:name><gtr:address><gtr:line1>Lazarettgasse 14</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/32E7600A-6119-4C42-8BB1-32EE10FCE29D"><gtr:id>32E7600A-6119-4C42-8BB1-32EE10FCE29D</gtr:id><gtr:firstName>Claus</gtr:firstName><gtr:surname>Nerlov</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0701761"><gtr:id>36CDB29F-83D3-42EE-8FCE-87D49D5EDE9E</gtr:id><gtr:title>Strategic Skills Award</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0701761</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:fund><gtr:end>2011-12-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2009-01-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>500200</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Austrian Academy of Sciences</gtr:collaboratingOrganisation><gtr:country>Austria, Republic of</gtr:country><gtr:department>Research Centre for Molecular Medicine (CeMM)</gtr:department><gtr:description>Hematopoiesis and leukemogenesis</gtr:description><gtr:id>7FE3BC57-A919-43EA-B47E-10ED0DB0FCC6</gtr:id><gtr:impact>Mancini E, Sanjuan-Pla A, Luciani L, Moore S, Grover A, Zay A, Rasmussen KD, Luc S, Bilbao D, O'Carroll D, Jacobsen SE, Nerlov C. FOG-1 and GATA-1 act sequentially to specify definitive megakaryocytic and erythroid progenitors. EMBO J. 2011 Nov 8. doi: 10.1038/emboj.2011.390

Kharazi S, Mead AJ, Mansour A, Hultquist A, B&amp;ouml;iers C, Luc S, Buza-Vidas N, Ma Z, Ferry H, Atkinson D, Reckzeh K, Masson K, Cammenga J, R&amp;ouml;nnstrand L, Arai F, Suda T, Nerlov C, Sitnicka E, Jacobsen SE. Impact of gene dosage, loss of wild-type allele, and FLT3 ligand on Flt3-ITD-induced myeloproliferation. Blood. 2011 Sep 29;118(13):3613-21.

Kaveri D., P. Kastner, D. Demb&amp;eacute;l&amp;eacute;, C. Nerlov, S. Chan and P. Kirstetter. 2013. ?-catenin activation synergizes with Pten loss and Myc overexpression in Notch-independent T-ALL. Blood 122: 694-704.

Zhang,H., M. Alberich-Jord&amp;agrave;, G. Amabile, H. Yang, P.B. Staber, A. DiRuscio, R.S. Welner, A. Ebralidze, J. Zhang, E. Levantini, V. Lefebvre, P.J.M. Valk, R. Delwel, M. Hoogenkamp, C. Nerlov, J. Cammenga, B. Saez, D.T. Scadden, C. Bonifer, M. Ye and D.G. Tenen. 2013. Sox4 is a key oncogenic target in C/EBPa mutant Acute Myeloid Leukemia. Cancer Cell 24: 575-88.

Grebien, F., M. Vedadi, M. Getlik, R. Giambruno, A. Grover, R. Avellino, A. Skucha, S. Vittori, E. Kuznetsova, D. Smil, D. Barsyte-Lovejoy, F. Li, G. Poda, M. Schapira, H. Wu, A. Dong, G. Senisterra, A. Stukalov, K.V.M. Huber, A. Sch&amp;ouml;negger, M. Bilban, C. Bock, P.J. Brown, J. Zuber, K.L. Bennett, R. Al-awar, R. Delwel, C. Nerlov, C.H. Arrowsmith and G. Superti-Furga. 2015. Pharmacological targeting of the Wdr5-MLL interaction in C/EBPa N-terminal leukemia. Nat. Chem. Biol. 11: 571-8.</gtr:impact><gtr:outcomeId>pPH9KX7nbr8-3</gtr:outcomeId><gtr:partnerContribution>Scientific discussion, methodology</gtr:partnerContribution><gtr:piContribution>Genetic modelling of hematopoiesis</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Karolinska Institute</gtr:collaboratingOrganisation><gtr:country>Sweden, Kingdom of</gtr:country><gtr:department>Department of Cell and Molecular Biology</gtr:department><gtr:description>Imaging of stem cell-niche interactions</gtr:description><gtr:id>302E6381-4FD7-4947-A8C8-9772E7AF0ACB</gtr:id><gtr:impact>No publications yet</gtr:impact><gtr:outcomeId>s9yzqPr844k-1</gtr:outcomeId><gtr:partnerContribution>Use of mouse models in neuronal and other non-hematopoietic tissues</gtr:partnerContribution><gtr:piContribution>Development of mouse models to identify cell-cell contact between stem cells and their niches in vivo using fluorescent complementation</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Harvard University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Harvard Stem Cell Institute</gtr:department><gtr:description>Hematopoiesis and leukemogenesis</gtr:description><gtr:id>5B1B155A-E067-4451-894C-B4E760E3ED8A</gtr:id><gtr:impact>Mancini E, Sanjuan-Pla A, Luciani L, Moore S, Grover A, Zay A, Rasmussen KD, Luc S, Bilbao D, O'Carroll D, Jacobsen SE, Nerlov C. FOG-1 and GATA-1 act sequentially to specify definitive megakaryocytic and erythroid progenitors. EMBO J. 2011 Nov 8. doi: 10.1038/emboj.2011.390

Kharazi S, Mead AJ, Mansour A, Hultquist A, B&amp;ouml;iers C, Luc S, Buza-Vidas N, Ma Z, Ferry H, Atkinson D, Reckzeh K, Masson K, Cammenga J, R&amp;ouml;nnstrand L, Arai F, Suda T, Nerlov C, Sitnicka E, Jacobsen SE. Impact of gene dosage, loss of wild-type allele, and FLT3 ligand on Flt3-ITD-induced myeloproliferation. Blood. 2011 Sep 29;118(13):3613-21.

Kaveri D., P. Kastner, D. Demb&amp;eacute;l&amp;eacute;, C. Nerlov, S. Chan and P. Kirstetter. 2013. ?-catenin activation synergizes with Pten loss and Myc overexpression in Notch-independent T-ALL. Blood 122: 694-704.

Zhang,H., M. Alberich-Jord&amp;agrave;, G. Amabile, H. Yang, P.B. Staber, A. DiRuscio, R.S. Welner, A. Ebralidze, J. Zhang, E. Levantini, V. Lefebvre, P.J.M. Valk, R. Delwel, M. Hoogenkamp, C. Nerlov, J. Cammenga, B. Saez, D.T. Scadden, C. Bonifer, M. Ye and D.G. Tenen. 2013. Sox4 is a key oncogenic target in C/EBPa mutant Acute Myeloid Leukemia. Cancer Cell 24: 575-88.

Grebien, F., M. Vedadi, M. Getlik, R. Giambruno, A. Grover, R. Avellino, A. Skucha, S. Vittori, E. Kuznetsova, D. Smil, D. Barsyte-Lovejoy, F. Li, G. Poda, M. Schapira, H. Wu, A. Dong, G. Senisterra, A. Stukalov, K.V.M. Huber, A. Sch&amp;ouml;negger, M. Bilban, C. Bock, P.J. Brown, J. Zuber, K.L. Bennett, R. Al-awar, R. Delwel, C. Nerlov, C.H. Arrowsmith and G. Superti-Furga. 2015. Pharmacological targeting of the Wdr5-MLL interaction in C/EBPa N-terminal leukemia. Nat. Chem. Biol. 11: 571-8.</gtr:impact><gtr:outcomeId>pPH9KX7nbr8-2</gtr:outcomeId><gtr:partnerContribution>Scientific discussion, methodology</gtr:partnerContribution><gtr:piContribution>Genetic modelling of hematopoiesis</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Pharmacology</gtr:department><gtr:description>Stem cell expansion</gtr:description><gtr:id>ECA8632B-67E7-46D6-B38A-64F2190DB7DD</gtr:id><gtr:impact>No publications yet</gtr:impact><gtr:outcomeId>rCCYt5tf5qc-1</gtr:outcomeId><gtr:partnerContribution>Generation of genetically modified mice allowing targeted over expression of candidate genes in specific stem cell populations</gtr:partnerContribution><gtr:piContribution>Analysis and functional characterisation of expanded stem/progenitor cell populations</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Molecular Haematology Unit</gtr:department><gtr:description>Hematopoiesis and leukemogenesis</gtr:description><gtr:id>F32156F9-D695-4932-925C-32F6C7CFAFD5</gtr:id><gtr:impact>Mancini E, Sanjuan-Pla A, Luciani L, Moore S, Grover A, Zay A, Rasmussen KD, Luc S, Bilbao D, O'Carroll D, Jacobsen SE, Nerlov C. FOG-1 and GATA-1 act sequentially to specify definitive megakaryocytic and erythroid progenitors. EMBO J. 2011 Nov 8. doi: 10.1038/emboj.2011.390

Kharazi S, Mead AJ, Mansour A, Hultquist A, B&amp;ouml;iers C, Luc S, Buza-Vidas N, Ma Z, Ferry H, Atkinson D, Reckzeh K, Masson K, Cammenga J, R&amp;ouml;nnstrand L, Arai F, Suda T, Nerlov C, Sitnicka E, Jacobsen SE. Impact of gene dosage, loss of wild-type allele, and FLT3 ligand on Flt3-ITD-induced myeloproliferation. Blood. 2011 Sep 29;118(13):3613-21.

Kaveri D., P. Kastner, D. Demb&amp;eacute;l&amp;eacute;, C. Nerlov, S. Chan and P. Kirstetter. 2013. ?-catenin activation synergizes with Pten loss and Myc overexpression in Notch-independent T-ALL. Blood 122: 694-704.

Zhang,H., M. Alberich-Jord&amp;agrave;, G. Amabile, H. Yang, P.B. Staber, A. DiRuscio, R.S. Welner, A. Ebralidze, J. Zhang, E. Levantini, V. Lefebvre, P.J.M. Valk, R. Delwel, M. Hoogenkamp, C. Nerlov, J. Cammenga, B. Saez, D.T. Scadden, C. Bonifer, M. Ye and D.G. Tenen. 2013. Sox4 is a key oncogenic target in C/EBPa mutant Acute Myeloid Leukemia. Cancer Cell 24: 575-88.

Grebien, F., M. Vedadi, M. Getlik, R. Giambruno, A. Grover, R. Avellino, A. Skucha, S. Vittori, E. Kuznetsova, D. Smil, D. Barsyte-Lovejoy, F. Li, G. Poda, M. Schapira, H. Wu, A. Dong, G. Senisterra, A. Stukalov, K.V.M. Huber, A. Sch&amp;ouml;negger, M. Bilban, C. Bock, P.J. Brown, J. Zuber, K.L. Bennett, R. Al-awar, R. Delwel, C. Nerlov, C.H. Arrowsmith and G. Superti-Furga. 2015. Pharmacological targeting of the Wdr5-MLL interaction in C/EBPa N-terminal leukemia. Nat. Chem. Biol. 11: 571-8.</gtr:impact><gtr:outcomeId>pPH9KX7nbr8-1</gtr:outcomeId><gtr:partnerContribution>Scientific discussion, methodology</gtr:partnerContribution><gtr:piContribution>Genetic modelling of hematopoiesis</gtr:piContribution><gtr:sector>Public</gtr:sector></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Blog on progenitor niches</gtr:description><gtr:form>Engagement focused website, blog or social media channel</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>12FC73F4-0DD6-42A5-80DF-6A3423F216B1</gtr:id><gtr:impact>Blog describing new knowledge gained on the nature of the transient niches used by differentiating progenitor cells in the thymus.</gtr:impact><gtr:outcomeId>56e186395ee051.24879967</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Undergraduate students</gtr:primaryAudience><gtr:url>http://www.imm.ox.ac.uk/wimm-blog-2</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Blog on platelet-biased hematopoietic stem cells.</gtr:description><gtr:form>Engagement focused website, blog or social media channel</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>AD6ECC4E-2FF0-4F52-B918-0CE972A8B87C</gtr:id><gtr:impact>Blog describing the identification of a new stem cell dedicated to preferential and rapid production of platelets (primary research published in Nature)</gtr:impact><gtr:outcomeId>56e186c75ef526.24876010</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.imm.ox.ac.uk/propagating-platelets-a-novel-cancer-therapy</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>2103093</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Programme Grant</gtr:description><gtr:end>2016-06-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>6A5DACFB-A4E1-480F-9696-3AA4F3AB8E1F</gtr:id><gtr:outcomeId>fvZS7RjS5Ko0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>175487</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>LLR Project Grant</gtr:description><gtr:end>2017-12-02</gtr:end><gtr:fundingOrg>Leukaemia and Lymphoma Research</gtr:fundingOrg><gtr:id>F64D7F2E-46C2-48D9-A789-99AB378BD8E9</gtr:id><gtr:outcomeId>56d72910165937.76750467</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>212400</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>AICR Project Grant</gtr:description><gtr:end>2015-09-02</gtr:end><gtr:fundingOrg>Association for International Cancer Research (AICR)</gtr:fundingOrg><gtr:fundingRef>11-0724</gtr:fundingRef><gtr:id>CA5EA655-6E37-4F7F-AB6C-0085C0742342</gtr:id><gtr:outcomeId>W7iZizJnd5B</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>233598</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>LLR Project Grant</gtr:description><gtr:end>2016-10-02</gtr:end><gtr:fundingOrg>Leukaemia and Lymphoma Research</gtr:fundingOrg><gtr:fundingRef>13008</gtr:fundingRef><gtr:id>C22D3462-5B23-4B3D-9E9C-473B9B480189</gtr:id><gtr:outcomeId>n84Ad1QUM7e</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>138724</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Gordon Piller Studentship</gtr:description><gtr:end>2018-09-02</gtr:end><gtr:fundingOrg>The Leukemia &amp; Lymphoma Society</gtr:fundingOrg><gtr:fundingRef>13064</gtr:fundingRef><gtr:id>C3E0D0F6-41E2-45AE-A366-F6727E837B1B</gtr:id><gtr:outcomeId>5460d488919f45.92588952</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2014-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>341857</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BBSRC Project Grant</gtr:description><gtr:end>2018-05-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:id>1BF80748-2A4D-4B55-AFFF-1278B7E2CB02</gtr:id><gtr:outcomeId>56d72a5d665cc0.02986630</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2015-11-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Danish Cancer Research Society</gtr:description><gtr:geographicReach>Europe</gtr:geographicReach><gtr:id>432ECFB1-395C-40A4-B9D4-77433A3C5115</gtr:id><gtr:impact>Funding allocation, clinical and basic cancer research</gtr:impact><gtr:outcomeId>56d72e43cf81f7.03416000</gtr:outcomeId><gtr:type>Membership of a guideline committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Danish Medical Research Council</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>0ADF223F-9AFA-45EF-9E4E-8BC5A0D05C90</gtr:id><gtr:impact>Increased funding for academic training of medical doctors, improved recruitment of early stage medicine student to research.</gtr:impact><gtr:outcomeId>PYHnhM8LgKH</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Using BAC transgenes expressing EGFP at high levels in platelets and erythoid cells we have generated a mouse line where production of cells of all lineages (myeloid, lymphoid, platelet, erythroid) from a stem cell or progenitor population can be monitored</gtr:description><gtr:id>10D5E033-3EF0-49C5-BCF4-43353977BA97</gtr:id><gtr:impact>One publication:

Mancini E, Sanjuan-Pla A, Luciani L, Moore S, Grover A, Zay A, Rasmussen KD, Luc S, Bilbao D, O'Carroll D, Jacobsen SE, Nerlov C. FOG-1 and GATA-1 act sequentially to specify definitive megakaryocytic and erythroid progenitors. EMBO J. 2011 Nov 8. doi: 10.1038/emboj.2011.390</gtr:impact><gtr:outcomeId>WoByojFKP15</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Complete hematopoietic reporter mouse</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2011</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Using knocking mutagenesis we have generated mouse lines that, when combined, precisely recapitulate the CEBPA mutations found in human patients with this type of acute myeloid leukaemia</gtr:description><gtr:id>62AAEFEA-8398-45DD-B771-02A4F41B0C12</gtr:id><gtr:impact>Publication:

Bereshchenko O, Mancini E, Moore S, Bilbao D, M&amp;aring;nsson R, Luc S, Grover A, Jacobsen SE, Bryder D, Nerlov C. Hematopoietic stem cell expansion precedes the generation of committed myeloid leukemia-initiating cells in C/EBPalpha mutant AML. Cancer Cell. 2009 Nov 6;16(5):390-400.

Reckzeh, K., O. Bereshchenko, A. Mead, M. Rehn, S. Kharazi, S.E. Jacobsen, C. Nerlov* and J. Cammenga*. 2012. Molecular and Cellular Effects of Oncogene Cooperation in a Genetically Accurate AML Mouse Model. Leukemia 26: 1527-36. (* Equal contribution).

One additional manuscript has been submitted</gtr:impact><gtr:outcomeId>jAwuE7o5Jud</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Model for CEBPA mutant AML</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type><gtr:yearFirstProvided>2009</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>1C2E349E-18DA-457E-BAF8-C9A1590D0B36</gtr:id><gtr:title>Hematopoietic Lineage Diversification, Simplified.</gtr:title><gtr:parentPublicationTitle>Cell stem cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5c898c712828706075492c628cb10fce"><gtr:id>5c898c712828706075492c628cb10fce</gtr:id><gtr:otherNames>Drissen R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1875-9777</gtr:issn><gtr:outcomeId>58bf5df3426324.54743782</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>58CC0408-F549-47BD-A729-CE016D169955</gtr:id><gtr:title>Platelet-biased stem cells reside at the apex of the haematopoietic stem-cell hierarchy.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9dcbcbb174ef85060f893c5185d2dbd0"><gtr:id>9dcbcbb174ef85060f893c5185d2dbd0</gtr:id><gtr:otherNames>Sanjuan-Pla A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>pm_15813_23_23934107</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1CBB3510-8078-46F4-9D1B-CC6F2C0BC133</gtr:id><gtr:title>Lineage-Biased Hematopoietic Stem Cells Are Regulated by Distinct Niches.</gtr:title><gtr:parentPublicationTitle>Developmental cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/127aa90c6f54d8da0bbfec4d510b9d96"><gtr:id>127aa90c6f54d8da0bbfec4d510b9d96</gtr:id><gtr:otherNames>Pinho S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>1534-5807</gtr:issn><gtr:outcomeId>5aa3a00e426427.19593511</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9B52EDC8-E331-4E9C-A8DE-9A388A4B864A</gtr:id><gtr:title>Wnt/?-Catenin Signaling Induces Integrin a4?1 in T Cells and Promotes a Progressive Neuroinflammatory Disease in Mice.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/17eb0be4d6301fb0b389983446d1d170"><gtr:id>17eb0be4d6301fb0b389983446d1d170</gtr:id><gtr:otherNames>Sorcini D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>5aa3a00dd01994.90058649</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6AA63D79-725E-4153-B46F-1A59019F75B3</gtr:id><gtr:title>Early myeloid lineage choice is not initiated by random PU.1 to GATA1 protein ratios.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b7672660229cf45e66d3c92b9dffa844"><gtr:id>b7672660229cf45e66d3c92b9dffa844</gtr:id><gtr:otherNames>Hoppe PS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>58bf5df36332b7.21179840</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>56F2E485-011A-4E02-B42E-EF482928BC2F</gtr:id><gtr:title>Dicer is selectively important for the earliest stages of erythroid development.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/867a455fe097c2dfa583641b7668df6a"><gtr:id>867a455fe097c2dfa583641b7668df6a</gtr:id><gtr:otherNames>Buza-Vidas N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>pm_15813_23_22869792</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D303F476-B0C4-4FBD-B6E2-3EAAC5BEA422</gtr:id><gtr:title>Pharmacological targeting of the Wdr5-MLL interaction in C/EBPa N-terminal leukemia.</gtr:title><gtr:parentPublicationTitle>Nature chemical biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/93aef8b7ba6f133aafd9c389794ee3b5"><gtr:id>93aef8b7ba6f133aafd9c389794ee3b5</gtr:id><gtr:otherNames>Grebien F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1552-4450</gtr:issn><gtr:outcomeId>56460a193e9700.89313794</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6E04458B-AD88-4627-BCF3-F428E88AA14C</gtr:id><gtr:title>Myelodysplastic syndromes are propagated by rare and distinct human cancer stem cells in vivo.</gtr:title><gtr:parentPublicationTitle>Cancer cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c678f61d9baba78039fd689d1985a666"><gtr:id>c678f61d9baba78039fd689d1985a666</gtr:id><gtr:otherNames>Woll PS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1535-6108</gtr:issn><gtr:outcomeId>5460ced22d8c44.14343025</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4F3F100C-6141-4E0A-9D5D-BB19689FA6A8</gtr:id><gtr:title>C/EBPalpha and beta couple interfollicular keratinocyte proliferation arrest to commitment and terminal differentiation.</gtr:title><gtr:parentPublicationTitle>Nature cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9044a0ffff1ec1ce52de855fa5f59539"><gtr:id>9044a0ffff1ec1ce52de855fa5f59539</gtr:id><gtr:otherNames>Lopez RG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1465-7392</gtr:issn><gtr:outcomeId>G9wYCjsmcJD</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F8BF6887-E7D9-4D88-A62C-DC3CDA232257</gtr:id><gtr:title>Pontin is essential for murine hematopoietic stem cell survival.</gtr:title><gtr:parentPublicationTitle>Haematologica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/87cd1e2035ae76105e5e9a85d40b112b"><gtr:id>87cd1e2035ae76105e5e9a85d40b112b</gtr:id><gtr:otherNames>Bereshchenko O</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0390-6078</gtr:issn><gtr:outcomeId>pm_15813_23_22371176</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8E17B050-7CFA-4FEA-BE3D-57319AB47005</gtr:id><gtr:title>?-Catenin activation synergizes with Pten loss and Myc overexpression in Notch-independent T-ALL.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fa8040e953163817d9a74aa7b2a54a3c"><gtr:id>fa8040e953163817d9a74aa7b2a54a3c</gtr:id><gtr:otherNames>Kaveri D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>pm_15813_23_23801632</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>90D7F75E-09D5-46C9-AB30-02B7E0E39EC2</gtr:id><gtr:title>Erratum: Pharmacological targeting of the Wdr5-MLL interaction in C/EBPa N-terminal leukemia.</gtr:title><gtr:parentPublicationTitle>Nature chemical biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/93aef8b7ba6f133aafd9c389794ee3b5"><gtr:id>93aef8b7ba6f133aafd9c389794ee3b5</gtr:id><gtr:otherNames>Grebien F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1552-4450</gtr:issn><gtr:outcomeId>58bf5df3847661.77917854</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9B263B8C-2CF0-4B47-8B80-858C3AED8654</gtr:id><gtr:title>Disease evolution and outcomes in familial AML with germline CEBPA mutations.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/89403228fb27ee0dc38ba211144ea08f"><gtr:id>89403228fb27ee0dc38ba211144ea08f</gtr:id><gtr:otherNames>Tawana K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>56460a191454e5.15556884</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B96BB7BA-5C24-4C67-B62C-2D56CD34C598</gtr:id><gtr:title>Single-cell RNA sequencing reveals molecular and functional platelet bias of aged haematopoietic stem cells.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/884a8401cd72205f42779a840d6a93a3"><gtr:id>884a8401cd72205f42779a840d6a93a3</gtr:id><gtr:otherNames>Grover A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>585d5178dd2f79.67555000</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>63AA8FED-CCA8-4E72-B411-0C53D80B6D03</gtr:id><gtr:title>A transit-amplifying population underpins the efficient regenerative capacity of the testis.</gtr:title><gtr:parentPublicationTitle>The Journal of experimental medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a9ee51a0c698b660ec3f3849c1a1dd6f"><gtr:id>a9ee51a0c698b660ec3f3849c1a1dd6f</gtr:id><gtr:otherNames>Carrieri C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0022-1007</gtr:issn><gtr:outcomeId>5aa3a02fa69340.81364500</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>08E8F615-47A2-4346-84DD-0869EB739E15</gtr:id><gtr:title>Canonical Notch signaling is dispensible for adult steady-state and stress myelo-erythropoiesis.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d78891d2f107dd298042f7e634936e4f"><gtr:id>d78891d2f107dd298042f7e634936e4f</gtr:id><gtr:otherNames>Duarte S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>5aa3a00e235e53.37953558</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B67829BE-EDC8-4E2B-83C0-3A0D4C937D08</gtr:id><gtr:title>A CREB-C/EBPbeta cascade induces M2 macrophage-specific gene expression and promotes muscle injury repair.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3f2cc47024e75fa42b1f840313de0629"><gtr:id>3f2cc47024e75fa42b1f840313de0629</gtr:id><gtr:otherNames>Ruffell D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>HSwZj4o8K2A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B50342C4-35CD-4D5D-B313-2CAA9A9A4326</gtr:id><gtr:title>Erythropoietin guides multipotent hematopoietic progenitor cells toward an erythroid fate.</gtr:title><gtr:parentPublicationTitle>The Journal of experimental medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/884a8401cd72205f42779a840d6a93a3"><gtr:id>884a8401cd72205f42779a840d6a93a3</gtr:id><gtr:otherNames>Grover A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-1007</gtr:issn><gtr:outcomeId>5460ced1e9aef1.87771856</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E990E928-84B8-4C2F-92CB-56E7B6C99E16</gtr:id><gtr:title>FOG-1 and GATA-1 act sequentially to specify definitive megakaryocytic and erythroid progenitors.</gtr:title><gtr:parentPublicationTitle>The EMBO journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1d76277cd7538daf1b6bdf3aee812312"><gtr:id>1d76277cd7538daf1b6bdf3aee812312</gtr:id><gtr:otherNames>Mancini E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0261-4189</gtr:issn><gtr:outcomeId>iKvER8FDNrc</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F2CF624A-63E8-4A51-8A1D-2318B7A319DD</gtr:id><gtr:title>A dynamic niche provides Kit ligand in a stage-specific manner to the earliest thymocyte progenitors.</gtr:title><gtr:parentPublicationTitle>Nature cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e241df9506cc57c225f4d67f9f5101c"><gtr:id>5e241df9506cc57c225f4d67f9f5101c</gtr:id><gtr:otherNames>Buono M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1465-7392</gtr:issn><gtr:outcomeId>56d6f43bebbb03.38982609</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E479B3DD-AD33-4AF8-8D1B-4F2A44FC7638</gtr:id><gtr:title>Initial seeding of the embryonic thymus by immune-restricted lympho-myeloid progenitors.</gtr:title><gtr:parentPublicationTitle>Nature immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6bc2a33653d404809acfd047a1a3aa3c"><gtr:id>6bc2a33653d404809acfd047a1a3aa3c</gtr:id><gtr:otherNames>Luis TC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1529-2908</gtr:issn><gtr:outcomeId>58bf5df2ecf194.07245212</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4F86E650-B06A-4E42-B8D9-5A08DF3F8D6E</gtr:id><gtr:title>DNA methylation protects hematopoietic stem cell multipotency from myeloerythroid restriction.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/58c4f93f6c3ff9963ccd99cdcb974746"><gtr:id>58c4f93f6c3ff9963ccd99cdcb974746</gtr:id><gtr:otherNames>Br?ske AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>actRMaC7ocY</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DD7FA2B7-339F-4C71-8CF2-090859433FED</gtr:id><gtr:title>Insights into specificity, redundancy and new cellular functions of C/EBPa and C/EBPb transcription factors through interactome network analysis.</gtr:title><gtr:parentPublicationTitle>Biochimica et biophysica acta</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d723d412fb322d4936f9996328f3af82"><gtr:id>d723d412fb322d4936f9996328f3af82</gtr:id><gtr:otherNames>Cirilli M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0006-3002</gtr:issn><gtr:outcomeId>58bf5df2b44b98.04193493</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>73B525B8-BD21-4F83-A219-B9E3084C7939</gtr:id><gtr:title>Impact of gene dosage, loss of wild-type allele, and FLT3 ligand on Flt3-ITD-induced myeloproliferation.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3f40f4f583726e10dea43821160160bc"><gtr:id>3f40f4f583726e10dea43821160160bc</gtr:id><gtr:otherNames>Kharazi S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>58bf5df425e537.46978220</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>66E80A63-C05F-45F9-9B9B-C460CF34D527</gtr:id><gtr:title>Chronic interleukin-1 exposure drives haematopoietic stem cells towards precocious myeloid differentiation at the expense of self-renewal.</gtr:title><gtr:parentPublicationTitle>Nature cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8b63a208352b53e745b735dad97dff01"><gtr:id>8b63a208352b53e745b735dad97dff01</gtr:id><gtr:otherNames>Pietras EM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1465-7392</gtr:issn><gtr:outcomeId>58bf5df31d7cc9.14931217</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8EC2C1F8-5464-4B68-BA57-BE2DAE93BF22</gtr:id><gtr:title>Hierarchically related lineage-restricted fates of multipotent haematopoietic stem cells.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3f038c872ebeffbfe50f3aa1d06b051c"><gtr:id>3f038c872ebeffbfe50f3aa1d06b051c</gtr:id><gtr:otherNames>Carrelha J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>5aa3a00e00ff23.12228016</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0DDB0E76-E7B8-467E-A34D-A88F63C69B5A</gtr:id><gtr:title>Distinct myeloid progenitor-differentiation pathways identified through single-cell RNA sequencing.</gtr:title><gtr:parentPublicationTitle>Nature immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5c898c712828706075492c628cb10fce"><gtr:id>5c898c712828706075492c628cb10fce</gtr:id><gtr:otherNames>Drissen R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1529-2908</gtr:issn><gtr:outcomeId>585d685e1889d2.63520150</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3ACC7C9F-FD7C-42FE-BC6B-53DE4EC06474</gtr:id><gtr:title>Niche-mediated depletion of the normal hematopoietic stem cell reservoir by Flt3-ITD-induced myeloproliferation.</gtr:title><gtr:parentPublicationTitle>The Journal of experimental medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5fb12a98d4056670ebefede87ebda6ba"><gtr:id>5fb12a98d4056670ebefede87ebda6ba</gtr:id><gtr:otherNames>Mead AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0022-1007</gtr:issn><gtr:outcomeId>5aa3a00d362266.64527857</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0701761</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>7C58A707-1BF6-4573-A44F-30B271C80813</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Cancer</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>